Ads
related to: global pharma healthcareobamacare-rates.com has been visited by 10K+ users in the past month
Search results
Poolbeg Pharma PLC Announces Results for the Year Ended 31 December 2023
Digital Journal· 9 hours ago...immunotherapy-induced CRS Independent Advisory Board of Key Opinion Leaders, healthcare payers and clinical trial experts, were supportive of POLB 001's potential to both prevent and treat cancer immunotherapy-induced ...Chairman Jeremy Skillington, PhD, Chief Executive Officer of Poolbeg Pharma,...
Geodis obtains IATA CEIV Pharma certification for its Copenhagen hub - The Loadstar
The Loadstar· 1 day agoGEODIS now has a total of 28 CEIV Pharma certified sites across its global network in the Americas,...
Earnings call: Astellas Pharma exceeds revenue forecast, faces profit dip By Investing.com
Investing.com· 18 hours agoAstellas Pharma Inc. (ALPMY) reported a surpassing of its full-year revenue forecast for FY 2023,...
7 Dividend Stocks to Buy Now for Steady Returns in Any Market
InvestorPlace· 3 days agoDividend stocks can be a great way to build wealth. If a stock market crash is predicted for the...
Earnings call: ResMed reports robust Q3 growth, plans for global expansion
Investing.com· 12 hours agoResMed Inc. (RMD), a global leader in digital health and cloud-connected medical devices for sleep...
Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and...
WTNH-TV New Haven· 5 days agoWorld Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme...
McKinsey Under Investigation Over Alleged Role In Fueling Opioid Epidemic
International Business Times· 5 days agoGlobal consulting firm McKinsey & Company is under a criminal investigation by the U.S. attorneys'...
Novo Nordisk (NYSE:NVO) and Eli Lilly (NYSE:LLY): Anti-Obesity Drug Market Could Reach Double...
The Wall Street Transcript· 2 days agoDr. Baum is the Global Head of Healthcare Research for Citi Research. Before joining Citi in 2011,...
Perrigo agrees to sell rare disease unit to Esteve for €275 million By Investing.com
Investing.com· 5 days agoPerrigo Company plc (NYSE:PRGO), a global player in consumer self-care products, has entered into a...
Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275...
FOX 4 Kansas City· 5 days ago("ESTEVE") has signed a binding offer to acquire Perrigo's HRA Pharma Rare Diseases business for a total consideration of up to €275 million, consisting of an upfront cash ...
